Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

Item
http://www.wikidata.org/entity/Q35308776
Therapeutic activity of NK cells against tumors.Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy.Natural killer cells: immunobiology and clinical prospects.Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.Predominance of BoCD8-positive T lymphocytes in vascular lesions in a 1-year-old cow with concurrent malignant catarrhal fever and bovine viral diarrhea virus infection.Lymphokine-activated killer cells: biology and relevance to disease.Natural killer cells and cancer.The role of autologous natural killer cells in chronic myelogenous leukemia.Augmentation of mouse natural killer (NK) activity by GM-1/P, a processed form of monosialoganglioside GM-1.Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells.Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy.Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.Natural killer cell activity of lymphocytes exposed to ovine, type I, trophoblast interferon.TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells.Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligan
P2860

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

Item
http://www.wikidata.org/entity/Q35308776
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@ast
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@en
type
label
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@ast
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@en
prefLabel
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@ast
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Lymphokine-activated killer ce ...... ogenitors in blood and spleen.
@en
P2093
P304
P31
P356
10.1016/0167-5699(87)90035-1
P433
P478
P50
P577
P698